Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank49
Year-over-Year Change
Year-over-year total asset growth rate
Latest
-5.07%
↓ 132% vs avg
Percentile
P49
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
15.93%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -5.07% |
| Q3 2025 | 35.99% |
| Q2 2025 | -3.61% |
| Q1 2025 | -1.42% |
| Q4 2024 | 7.89% |
| Q3 2024 | -4.79% |
| Q2 2024 | 47.63% |
| Q1 2024 | -22.27% |
| Q4 2023 | -6.06% |
| Q3 2023 | 14.28% |
| Q2 2023 | -10.34% |
| Q1 2023 | -9.62% |
| Q4 2022 | -1.83% |
| Q3 2022 | 40.31% |
| Q2 2022 | -2.51% |
| Q1 2022 | -13.56% |
| Q4 2021 | -7.39% |
| Q3 2021 | -8.39% |
| Q2 2021 | -8.01% |
| Q1 2021 | 125.69% |
| Q4 2020 | -13.18% |
| Q3 2020 | -11.50% |
| Q2 2020 | -11.06% |
| Q1 2020 | -11.27% |
| Q4 2019 | 73.78% |
| Q3 2019 | -15.82% |
| Q2 2019 | -10.83% |
| Q1 2019 | -9.11% |
| Q4 2018 | -6.31% |
| Q3 2018 | -4.81% |
| Q2 2018 | 109.22% |
| Q1 2018 | -8.10% |
| Q4 2017 | 335.97% |
| Q3 2017 | -14.86% |
| Q2 2017 | 57.03% |
| Q1 2017 | 110.98% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |